StockDrifts LogoStockDrifts

Shinshin Pharmaceutical 002800

Company
신신제약Shinshin Pharmaceutical
Insiders
5
Buys
7
Total Value
₩126M ($87K)
Avg Return
-18.20%
Last Filing
2026-06-30

Shinshin Pharmaceutical (002800) has 7 disclosed insider purchases and 4 disclosed disposals on record, filed by 5 distinct insiders. Together those filings cover ₩126M ($87K) in reported transaction value. The earliest filing StockDrifts holds for Shinshin Pharmaceutical is dated 2021-06-08; the most recent is 2026-06-30. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is -18.20%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2026-06-30BUYMarket Buy
김상경
Kim Sang-kyung
Managing Director700---
2026-06-29BUYMarket Buy
김상경
Kim Sang-kyung
Managing Director500---
2026-06-24BUYMarket Buy
김상경
Kim Sang-kyung
Managing Director500---
2026-06-15BUYMarket Buy
김상경
Kim Sang-kyung
Managing Director300---
2025-10-27SELLMarket Sell
윤광철
Gwangcheol Yoon
Managing Director-5.0K₩5,400-16.3%₩27M ($19K)
2025-10-01SELLMarket Sell
신성학
divinity
moving-7.6K₩5,570-12.8%₩43M ($30K)
2025-09-29BUY기타
신성학
divinity
moving6.4K₩5,660+10.9%₩36M ($25K)
2025-01-21SELLMarket Sell
이종민
Jongmin Lee
Managing Director-7.5K₩5,430-15.7%₩41M ($28K)
2025-01-20SELLMarket Sell
이종민
Jongmin Lee
Managing Director-2.5K₩5,520-13.8%₩14M ($10K)
2025-01-10BUY기타
윤광철
Gwangcheol Yoon
Managing Director5.0K₩5,700+10.2%₩29M ($20K)
2025-01-09BUY기타
이종민
Jongmin Lee
Managing Director10.0K₩5,700+10.2%₩57M ($40K)
2024-03-25SELL임원퇴임
박노석
Noseok Park
Other non-executive directors-46.7K₩6,750+7.0%₩315M ($219K)
2023-07-28BUYMarket Buy
김상경
Kim Sang-kyung
Managing Director200---
2021-06-09BUYMarket Buy
박노석
Noseok Park
Other non-executive directors100₩8,380-25.1%₩838K ($582)
2021-06-08BUYMarket Buy
박노석
Noseok Park
Other non-executive directors80₩8,450-25.7%₩676K ($469)

Frequently asked questions

Who has been buying Shinshin Pharmaceutical stock?
5 distinct insiders have filed 7 disclosed insider purchases in Shinshin Pharmaceutical (002800), most recently on 2026-06-30. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Shinshin Pharmaceutical have?
Shinshin Pharmaceutical has 7 buy-side and 4 sell-side disclosures on record, covering ₩126M ($87K) in total reported value, spanning 2021-06-08 to 2026-06-30.
Where does StockDrifts get Shinshin Pharmaceutical insider data?
From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Source filings

Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Shinshin Pharmaceutical. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.